Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation (Q40075380)

17 September 2017

title

Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation (English)

1 reference

17 September 2017

main subject

Streptococcus pyogenes

object named as

Streptococcus pyogenes

1 reference

6

1 reference

17 September 2017

7

Anna Norrby-Teglund

0 references

Malak Kotb

5

object named as

Malak Kotb

1 reference

17 September 2017

3

Jessica Darenberg

1 reference

17 September 2017

Lisa I Påhlman

1

1 reference

17 September 2017

Anders I Olin

2

1 reference

17 September 2017

Matthias Mörgelin

4

1 reference

17 September 2017

Anna Norrby-Teglund

7

1 reference

17 September 2017

publication date

28 September 2007

1 reference

17 September 2017

published in

Cellular Microbiology

1 reference

17 September 2017

volume

10

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

404-414

1 reference

M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Pathogenesis of group A streptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Streptococcal M protein: molecular design and biological behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

FIBRINOGEN PRECIPITATION BY STREPTOCOCCAL M PROTEIN. I. IDENTITY OF THE REACTANTS, AND STOICHIOMETRY OF THE REACTION

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

TLR2 is expressed on activated T cells as a costimulatory receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Superantigens: microbial agents that corrupt immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Toxic shock syndrome and bacterial superantigens: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

The staphylococcal enterotoxins and their relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Intravenous Immunoglobulin Adjunctive Therapy in Sepsis, with Special Emphasis on Severe Invasive Group A Streptococcal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Streptococcal M protein: a multipotent and powerful inducer of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Peripheral blood mononuclear cells proliferation and Th1/Th2 cytokine production in response to streptococcal M protein in psoriatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

21 January 2018

Bacterial superantigens

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Identification and characterization of novel superantigens from Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Toxin‐Gene Profile Heterogeneity among Endemic Invasive European Group A Streptococcal Isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

Superantigenicity of streptococcal M protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

T cell receptor V gene usage by human T cells stimulated with the superantigen streptococcal M protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1462-5822.2007.01053.X

10.1111/J.1462-5822.2007.01053.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference